| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And COO
1 company
Cohlhepp Ryan is a President And COO at Bicara Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | BCAX Bicara Therapeutics Inc. | President And COO | Sale+OE | 12,500 | $20.29 | $253,648.75 | -3.1% | - | - | |
| Mar 16, 2026 | BCAX Bicara Therapeutics Inc. | President And COO | Sale+OE | 12,500 | $19.66 | $245,713.75 | -3.0% | +11.8% | - | |
| Jan 15, 2026 | BCAX Bicara Therapeutics Inc. | President And COO | Sell | 149 | $18.02 | $2,684.98 | - | +26.5% | - | |
| Dec 15, 2025 | BCAX Bicara Therapeutics Inc. | President And COO | Sale+OE | 12,500 | $18.68 | $233,547.50 | -3.2% | +5.7% | - | |
| Nov 21, 2025 | BCAX Bicara Therapeutics Inc. | President And COO | Sale+OE | 12,500 | $18.05 | $225,587.50 | -3.1% | -14.5% | - | |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | President And COO | Sale+OE | 12,500 | $18.16 | $226,942.50 | -3.0% | -6.8% | - | |
| Oct 7, 2025 | BCAX Bicara Therapeutics Inc. | President And COO | Sale+OE | 50,500 | $18.06 | $911,841.99 | -5.7% | -11.3% | - |